The COVID-19 outbreak, spreading like wildfire across the globe, has turned out to be tailwind for Getinge’s critical care business. With the infection spreading to more countries/regions, this brings added business to the firm’s acute care business, which could help support Getinge’s stock price in these volatile times.
